Mediaboss Marketing

Technavio has been monitoring the precision medicine software market and it is poised to grow by USD 882.65 mn during 2020-2024, progressing at a CAGR of about 11% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200921005394/en/

Technavio has announced its latest market research report titled Global Precision Medicine Software Market 2020-2024 (Graphic: Business Wire)

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Frequently Asked Questions:

What are the major trends in the market? Digitization of healthcare is a major trend driving the growth of the market.

At what rate is the market projected to grow? The year-over-year growth for 2020 is estimated at 10.90% and the incremental growth of the market is anticipated to be $ 882.65 mn.

Who are the top players in the market? F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA, and Syapse Inc., are some of the major market participants.

What is the key market driver? The benefits of precision medicine is one of the major factors driving the market.

How big is the North America market? The North America region will contribute 45% of the market share.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA, and Syapse Inc. are some of the major market participants. The benefits of precision medicine will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Story continues

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Precision Medicine Software Market 2020-2024: Segmentation

Precision Medicine Software Market is segmented as below:

Delivery Mode

Geographic Landscape

Asia

Europe

North America

ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40844

Precision Medicine Software Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The precision medicine software market report covers the following areas:

Precision Medicine Software Market Size

Precision Medicine Software Market Trends

Precision Medicine Software Market Industry Analysis

This study identifies the digitization of healthcare as one of the prime reasons driving the Precision Medicine Software Market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform

Precision Medicine Software Market 2020-2024: Key Highlights

CAGR of the market during the forecast period 2020-2024

Detailed information on factors that will assist precision medicine software market growth during the next five years

Estimation of the precision medicine software market size and its contribution to the parent market

Predictions on upcoming trends and changes in consumer behavior

The growth of the precision medicine software market

Analysis of the markets competitive landscape and detailed information on vendors

Comprehensive details of factors that will challenge the growth of precision medicine software market vendors

Table of Contents:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY DELIVERY MODE

Market segmentation by delivery mode

Comparison by delivery mode

On-premise - Market size and forecast 2019-2024

Cloud-based - Market size and forecast 2019-2024

Market opportunity by delivery mode

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America - Market size and forecast 2019-2024

Europe - Market size and forecast 2019-2024

Asia - Market size and forecast 2019-2024

ROW - Market size and forecast 2019-2024

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

Rise in clinical trials in developing nations

Digitization of healthcare

Improvement in healthcare and IT infrastructure in emerging economies

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

F. Hoffmann-La Roche Ltd.

Fabric Genomics, Inc.

Gene42 Inc.

Human Longevity, Inc.

International Business Machines Corp.

Koninklijke Philips NV

NantHealth Inc.

Roper Technologies Inc.

SOPHiA GENETICS SA

Syapse Inc.

PART 14: APPENDIX

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200921005394/en/

Contacts

Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@technavio.com Website: http://www.technavio.com/

View original post here:
Precision Medicine Software Market- Roadmap for Recovery from COVID-19|Benefits Of Precision Medicine to Boost the Market Growth | Technavio - Yahoo...